Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating the Safety and Efficacy of a Probiotic on IBS Symptom Severity in Adults With Diarrhoea-predominant Irritable Bowel Syndrome

NCT05754177 is registered in ClinicalTrials.gov with The Archer-Daniels-Midland Company as lead sponsor.

NCT NCT05754177
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05754177 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating the Safety and Efficacy of a Probiotic on IBS Symptom Severity in Adults With Diarrhoea-predominant Irritable Bowel Syndrome
Lead sponsor
The Archer-Daniels-Midland Company
Phase
Not applicable
Overall status
Completed
Start date
June 6, 2023
Completion date
December 30, 2024
Enrollment
46 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

irritable bowel syndrome, irritable bowel syndrome with diarrhea